Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This image of a blood clot composed of erythrocytes trapped by long fibrous chains of fibrin was judged the winner of the image competition at the BHF CRE 2022 Symposiium, held in December. In this image we can see false coloured erythrocytes (classic biconcave appearance around 5-10 µm in diameter) wrapped by fibrin network.

An image of a blood clot composed of erythrocytes trapped by long fibrous chains of fibrin - the image shows false coloured erythrocytes (classic biconcave appearance around 5-10 µm in diameter) wrapped by fibrin network

Patients receive a high dose of heparin so that they don’t clot during cardiopulmonary bypass (CPB) surgery. These patients receive a drug protamine to reverse and neutralize the anticoagulant effects of heparin post-CPB. The quality of these clots post reversal are poor compared to normal highlighting that the dose of the reversal agent is critical.  

Recently, Miles et al 2021 (Plos Medicine) used a mathematical model to guide protamine dosing and showed it improved thromboelastography r-time and reduced the dose administered relative to a fixed ratio. 

Using Scanning electron microscopy, the group is able to assess blood clot quality and fibrin characteristics. This is an ongoing study with clinicians Daniel Aston and Florian Falter at Papworth Hospital Cambridge to assess clot quality. 

Images were captured on a Zeiss Sigma 300 FEG-SEM in the Dunn School of Pathology, Electron Microscopy Facility. False colouring performed in Adobe Photoshop by Dr Samuel Bose.